Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Meningeal Neoplasms 1Melanoma 1Lung Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Trastuzumab 4Capecitabine 4tucatinib 3fludarabine 2Spinal Puncture 2Radiotherapy 2Nivolumab 2Methotrexate 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2sapanisertib 1pertuzumab 1patritumab deruxtecan 1paclitaxel-Angiopep-2 conjugate 1mafosfamide 1gadopiclenol 1gadobutrol 1fludarabine phosphate 1eribulin 1avelumab 1aldesleukin 1WP 744 1Topotecan 1Temozolomide 1Specimen Handling 1Rituximab 1Phlebotomy 1Mesna 1Interleukin-2 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Meningeal Neoplasms × gadopiclenol × Clear all
NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡